SB-691673
| SB-691673_structure.png | |
SB-691673 is a chemical compound that has been studied for its potential pharmacological effects. It is primarily known as a selective antagonist of the 5-HT6 receptor, which is a subtype of the serotonin receptor family. The 5-HT6 receptor is predominantly expressed in the central nervous system, particularly in regions such as the cortex, hippocampus, and striatum.
Pharmacology[edit | edit source]
SB-691673 acts as a selective antagonist at the 5-HT6 receptor. This receptor is involved in the modulation of neurotransmitter release, including acetylcholine, dopamine, and glutamate. By blocking the 5-HT6 receptor, SB-691673 may influence cognitive processes, making it a compound of interest in the study of cognitive disorders such as Alzheimer's disease and schizophrenia.
Mechanism of Action[edit | edit source]
The 5-HT6 receptor is a G-protein coupled receptor (GPCR) that is positively coupled to adenylate cyclase. When activated by its endogenous ligand, serotonin, it increases the levels of cyclic AMP (cAMP) within the cell. SB-691673, by acting as an antagonist, inhibits this pathway, potentially leading to altered neurotransmitter release and modulation of synaptic plasticity.
Research and Development[edit | edit source]
SB-691673 has been the subject of various preclinical studies to evaluate its effects on cognition and behavior. Animal studies have shown that SB-691673 can improve performance in tasks that require learning and memory, suggesting its potential utility in treating cognitive impairments.
Potential Therapeutic Applications[edit | edit source]
Given its role in modulating neurotransmitter systems involved in cognition, SB-691673 is being investigated for its potential use in treating conditions such as:
Safety and Side Effects[edit | edit source]
As with any investigational drug, the safety profile of SB-691673 is still under evaluation. Preclinical studies have not reported significant adverse effects, but further research is necessary to fully understand its safety in humans.
Also see[edit | edit source]
 | This article about a biochemical receptor is a stub. You can help WikiMD by expanding it. |
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
